Medical Device Excise Tax Repeal Passes in the House
Posted July 25, 2018
Today the U.S. House of Representatives passed the Protect Medical Innovation Act (H.R.184) which has been championed by Rep. Erik Paulsen (R-MN) by a vote of 283-132. This bipartisan legislation permanently repeals the medical device excise tax imposed as part of the Affordable Care Act. This vote puts pressure on the U.S. Senate to act as well to once and for all to repeal this burdensome tax.
H.R. 195 (Pub. L. 115-120), signed into law on Jan. 22, 2018, extended for an additional two years the moratorium on the medical device excise tax imposed by Internal Revenue Code section 4191. Because of the moratorium, the medical device excise tax does not apply to the sale of taxable medical devices by the manufacturer, producer or importer of the device during the period beginning on Jan. 1, 2016, and ending on Dec. 31, 2019.
Updated talking points for DTA Members to use when contacting their Senators:
- The Dental Trade Alliance is a strong supporter of the Protect Medical Innovation Act (H.R.184) introduced by Rep. Eric Paulsen in the House of Representatives.
- As a member of the Dental Trade Alliance, I urge you to vote for H.R.184 when it comes to the floor for a vote today. H.R.184 would repeal of the medical device excise tax because it harms job creation, deters innovation and impedes economic growth.
- On January 22, 2018, Congress suspended the medical device excise tax for two years. While this was a positive step forward, dental manufacturers continue to support full repeal of this harmful tax.
- Strong bipartisan support exists for repealing the medical device excise tax. I would appreciate your vote on this important legislation today.